These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2892922)
1. Effect of trimethoprim, paracetamol and cimetidine on trimetrexate metabolism by rat perfused isolated livers. Webster LK; Tong WP; McCormack JJ J Pharm Pharmacol; 1987 Nov; 39(11):942-4. PubMed ID: 2892922 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and biliary excretion of trimetrexate by the isolated perfused rat liver. Webster LK; Tong WP; McCormack JJ Cancer Lett; 1985 Oct; 29(1):65-71. PubMed ID: 2933139 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic study of trimetrexate in combination with cisplatin. Hudes GR; LaCreta F; Walczak J; Tinsley P; Litwin S; Comis RL; O'Dwyer PJ Cancer Res; 1991 Jun; 51(12):3080-7. PubMed ID: 1828188 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer. Reece PA; Morris RG; Bishop JF; Olver IN; Raghavan D Cancer Res; 1987 Jun; 47(11):2996-9. PubMed ID: 2952262 [TBL] [Abstract][Full Text] [Related]
5. Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracil. Hudes GR; LaCreta F; DeLap RJ; Grillo-Lopez AJ; Catalano R; Comis RL Cancer Chemother Pharmacol; 1989; 24(2):117-22. PubMed ID: 2525077 [TBL] [Abstract][Full Text] [Related]
6. A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics. Grochow LB; Noe DA; Ettinger DS; Donehower RC Cancer Chemother Pharmacol; 1989; 24(5):314-20. PubMed ID: 2758561 [TBL] [Abstract][Full Text] [Related]
7. Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog. Wong BK; Woolf TF; Chang T; Whitfield LR Drug Metab Dispos; 1990; 18(6):980-6. PubMed ID: 1981548 [TBL] [Abstract][Full Text] [Related]
8. Quantitation of folic acid enhancement of antifolate synergism. Gaumont Y; Kisliuk RL; Parsons JC; Greco WR Cancer Res; 1992 Apr; 52(8):2228-35. PubMed ID: 1532766 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man. Mitchell MC; Schenker S; Speeg KV J Clin Invest; 1984 Feb; 73(2):383-91. PubMed ID: 6142056 [TBL] [Abstract][Full Text] [Related]
10. Phase I studies of trimetrexate using single and weekly dose schedules. Huan SD; Legha SS; Raber MN; Krakoff IH Invest New Drugs; 1991 May; 9(2):199-206. PubMed ID: 1831442 [TBL] [Abstract][Full Text] [Related]
11. Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics. Grochow LB; Noe DA; Dole GB; Rowinsky EK; Ettinger DS; Graham ML; McGuire WP; Donehower RC J Natl Cancer Inst; 1989 Jan; 81(2):124-30. PubMed ID: 2909752 [TBL] [Abstract][Full Text] [Related]
12. A phase I and pharmacokinetic study of trimetrexate using a 24-hour continuous-injection schedule. Allegra CJ; Jenkins J; Weiss RB; Balis F; Drake JC; Brooks J; Thomas R; Curt GA Invest New Drugs; 1990 May; 8(2):159-66. PubMed ID: 2143500 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat. Coleman MD; Russell RM; Tingle MD; Park BK J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of metabolism of the 'nonclassical' antifolate, trimetrexate (2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline) by drugs containing an imidazole moiety. Heusner JJ; Franklin MR Pharmacology; 1985; 30(5):266-72. PubMed ID: 3159026 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of trimetrexate, a potent lipid-soluble antifolate, in the treatment of rodent Pneumocystis carinii pneumonia. Kovacs JA; Allegra CJ; Kennedy S; Swan JC; Drake J; Parrillo JE; Chabner B; Masur H Am J Trop Med Hyg; 1988 Nov; 39(5):491-6. PubMed ID: 2973755 [TBL] [Abstract][Full Text] [Related]
17. Cimetidine and omeprazole do not affect cyclosporine disposition by the rat liver. Bar-Meir S; Bardan E; Ronen I; Krepel Z; Garti M Eur J Drug Metab Pharmacokinet; 1993; 18(4):355-8. PubMed ID: 8020534 [TBL] [Abstract][Full Text] [Related]
18. The inhibitory effects of ranitidine and cimetidine on propranolol elimination by the rat isolated perfused liver. Jones DB; Ching MS; Morgan DJ; Anderson JD; Smallwood RA J Pharm Pharmacol; 1985 Mar; 37(3):196-8. PubMed ID: 2858568 [TBL] [Abstract][Full Text] [Related]
19. The effect of cimetidine and ranitidine on paracetamol glucuronidation and sulphation in cultured rat hepatocytes. Emery S; Oldham HG; Norman SJ; Chenery RJ Biochem Pharmacol; 1985 May; 34(9):1415-21. PubMed ID: 3994756 [TBL] [Abstract][Full Text] [Related]
20. Carbaryl metabolism is inhibited by cimetidine in the isolated perfused rat liver and in man. Ward SA; May DG; Heath AJ; Branch RA J Toxicol Clin Toxicol; 1988; 26(5-6):269-81. PubMed ID: 3143015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]